Evidence map›Paper›PMID 21145576›Full record

ArticleActa histochemica2011

Candidate genes contributing to the aggressive phenotype of mantle cell lymphoma.

Sarah E Henson, Travis Morford, Mary-Pat Stein, Randolph Wall, Cindy S Malone

Open access · greenAbstract read
In one paragraph

Article in Acta histochemica, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sarah E HensonDepartment of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California Los Angeles, 90095, USA.
Travis Morford
Mary-Pat Stein
Randolph Wall
Cindy S Malone
California State University, Northridge · USUniversity of California, Los Angeles · US

Funding

UCLA NIGMS T32 Program AssessmentT32GM007185 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TORRES, JORGE · 1985 to 2020
$21.7M
CONTROL OF LYMPHOCYTE DEVELOPMENTR01GM040185 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WALL, RANDOLPH · 1988 to 2005
$1.7M
NOVEL MECHANISMS IN B CELL LEUKEMOGENESISR01CA085841 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WALL, RANDOLPH · 2001 to 2005
$1.3M
CCWGG methylation in developmentally regulated B cell-specific gene silencingR15GM080683 · NIGMS · CALIFORNIA STATE UNIVERSITY NORTHRIDGE · PI MALONE, CINDY SUE · 2007 to 2007
$215k
NCI NIH HHS CA85841NCI NIH HHS R01 CA085841NCI NIH HHS R01CA74929NIGMS NIH HHS GM07185NIGMS NIH HHS GM40185NIGMS NIH HHS R01 GM040185NIGMS NIH HHS R15 GM080683NIGMS NIH HHS R15GM080683-01NIGMS NIH HHS T32 GM007185
6 · The paper itself

Abstract

Mantle cell lymphoma and small lymphocytic lymphoma are lymphocyte cancers that have similar morphologies and a common age of onset. Mantle cell lymphoma is generally an aggressive B cell lymphoma with a short median survival time, whereas small lymphocytic lymphoma is typically an indolent B cell lymphoma with a prolonged median survival time. Using primary tumor samples in bi-directional suppression subtractive hybridization, we identified genes with differential expression in an aggressive mantle cell lymphoma versus an indolent small lymphocytic lymphoma. "Virtual" Northern blot analyses of multiple lymphoma samples confirmed that a set of genes was preferentially expressed in aggressive mantle cell lymphoma compared to indolent small lymphocytic lymphoma. These analyses identified mantle cell lymphoma-specific genes that may be involved in the aggressive behavior of mantle cell lymphoma and possibly other aggressive human lymphomas. Interestingly, most of these differentially expressed genes have not been identified using other techniques, highlighting the unique ability of suppression subtractive hybridization to identify potentially rare or low expression genes.

Indexed as

DNA, ComplementaryHumansLeukemia, Lymphocytic, Chronic, B-CellLymphoma, Mantle-CellPhenotypeSequence Analysis, DNADNA, Complementary

Identifiers

PMID21145576
PMCPMC4657859
OpenAlexW2065524725

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.